Статті в журналах з теми "DYRK2"
Оформте джерело за APA, MLA, Chicago, Harvard та іншими стилями
Ознайомтеся з топ-50 статей у журналах для дослідження на тему "DYRK2".
Біля кожної праці в переліку літератури доступна кнопка «Додати до бібліографії». Скористайтеся нею – і ми автоматично оформимо бібліографічне посилання на обрану працю в потрібному вам стилі цитування: APA, MLA, «Гарвард», «Чикаго», «Ванкувер» тощо.
Також ви можете завантажити повний текст наукової публікації у форматі «.pdf» та прочитати онлайн анотацію до роботи, якщо відповідні параметри наявні в метаданих.
Переглядайте статті в журналах для різних дисциплін та оформлюйте правильно вашу бібліографію.
Correa-Sáez, Alejandro, Rafael Jiménez-Izquierdo, Martín Garrido-Rodríguez, Rosario Morrugares, Eduardo Muñoz, and Marco A. Calzado. "Updating dual-specificity tyrosine-phosphorylation-regulated kinase 2 (DYRK2): molecular basis, functions and role in diseases." Cellular and Molecular Life Sciences 77, no. 23 (May 27, 2020): 4747–63. http://dx.doi.org/10.1007/s00018-020-03556-1.
Повний текст джерелаKinstrie, Ross, Pamela A. Lochhead, Gary Sibbet, Nick Morrice, and Vaughn Cleghon. "dDYRK2 and Minibrain interact with the chromatin remodelling factors SNR1 and TRX." Biochemical Journal 398, no. 1 (July 27, 2006): 45–54. http://dx.doi.org/10.1042/bj20060159.
Повний текст джерелаBanerjee, Sourav, Chenggong Ji, Joshua E. Mayfield, Apollina Goel, Junyu Xiao, Jack E. Dixon, and Xing Guo. "Ancient drug curcumin impedes 26S proteasome activity by direct inhibition of dual-specificity tyrosine-regulated kinase 2." Proceedings of the National Academy of Sciences 115, no. 32 (July 9, 2018): 8155–60. http://dx.doi.org/10.1073/pnas.1806797115.
Повний текст джерелаSeo, D. H., H. W. Ma, S. Kim, D. H. Kim, H. K. Kim, S. H. Lee, S. Kim, et al. "P001 The novel DYRK1a inhibitor VRN024219 alleviates disease severity on the IBD mouse models by modulating T-cell differentiation." Journal of Crohn's and Colitis 14, Supplement_1 (January 2020): S129. http://dx.doi.org/10.1093/ecco-jcc/jjz203.130.
Повний текст джерелаBanerjee, Sourav, Tiantian Wei, Jue Wang, Jenna J. Lee, Haydee L. Gutierrez, Owen Chapman, Sandra E. Wiley, et al. "Inhibition of dual-specificity tyrosine phosphorylation-regulated kinase 2 perturbs 26S proteasome-addicted neoplastic progression." Proceedings of the National Academy of Sciences 116, no. 49 (November 21, 2019): 24881–91. http://dx.doi.org/10.1073/pnas.1912033116.
Повний текст джерелаPark, Chun Shik, Ye Shen, Koramit Suppipat, Andrew Lewis, Julie Tomolonis, Monica Puppi, toni-Ann Mistretta, Leyuan Ma, Michael R. Green, and Daniel Lacorazza. "DYRK2 Inhibits the Self-Renewal of Leukemic Stem Cells in Chronic Myeloid Leukemia By Inducing Degradation of c-Myc Downstream of the Reprogramming Factor KLF4." Blood 128, no. 22 (December 2, 2016): 1879. http://dx.doi.org/10.1182/blood.v128.22.1879.1879.
Повний текст джерелаMao, Cui, Xing Ju, Haijian Cheng, Xixia Huang, Fugui Jiang, Yuni Yao, Xianyong Lan, and Enliang Song. "Determination of genetic variation within the <i>DYRK2</i> gene and its associations with milk traits in cattle." Archives Animal Breeding 63, no. 2 (September 9, 2020): 315–23. http://dx.doi.org/10.5194/aab-63-315-2020.
Повний текст джерелаMorrugares, Rosario, Alejandro Correa-Sáez, Rita Moreno, Martín Garrido-Rodríguez, Eduardo Muñoz, Laureano de la Vega, and Marco A. Calzado. "Phosphorylation-dependent regulation of the NOTCH1 intracellular domain by dual-specificity tyrosine-regulated kinase 2." Cellular and Molecular Life Sciences 77, no. 13 (October 11, 2019): 2621–39. http://dx.doi.org/10.1007/s00018-019-03309-9.
Повний текст джерелаShen, Yifen, Li Zhang, Donglin Wang, Yifeng Bao, Chao Liu, Zhiwei Xu, Wei Huang, and Chun Cheng. "Regulation of Glioma Cells Migration by DYRK2." Neurochemical Research 42, no. 11 (July 4, 2017): 3093–102. http://dx.doi.org/10.1007/s11064-017-2345-2.
Повний текст джерелаAman, La Ode, Rahmana Emran Kartasasmita, and Daryono Hadi Tjahjono. "Virtual screening of curcumin analogues as DYRK2 inhibitor: Pharmacophore analysis, molecular docking and dynamics, and ADME prediction." F1000Research 10 (May 17, 2021): 394. http://dx.doi.org/10.12688/f1000research.28040.1.
Повний текст джерелаOng, Su Sien, Asli N. Goktug, Ayesha Elias, Jing Wu, Darren Saunders, and Taosheng Chen. "Stability of the human pregnane X receptor is regulated by E3 ligase UBR5 and serine/threonine kinase DYRK2." Biochemical Journal 459, no. 1 (March 14, 2014): 193–203. http://dx.doi.org/10.1042/bj20130558.
Повний текст джерелаErickson-Miller, Connie L., Caretha Creasy, Antony Chadderton, Christopher B. Hopson, Elizabeth I. Valoret, Michele Gorczyca, Louis Elefante, et al. "GSK626616: A DYRK3 Inhibitor as a Potential New Therapy for the Treatment of Anemia." Blood 110, no. 11 (November 16, 2007): 510. http://dx.doi.org/10.1182/blood.v110.11.510.510.
Повний текст джерелаPark, Chun Shik, and H. Daniel Lacorazza. "DYRK2 controls a key regulatory network in chronic myeloid leukemia stem cells." Experimental & Molecular Medicine 52, no. 10 (October 2020): 1663–72. http://dx.doi.org/10.1038/s12276-020-00515-5.
Повний текст джерелаSun, Yuxiang, Xin Ge, Mengmeng Li, Li Xu, and Yaodong Shen. "Dyrk2 involved in regulating LPS-induced neuronal apoptosis." International Journal of Biological Macromolecules 104 (November 2017): 979–86. http://dx.doi.org/10.1016/j.ijbiomac.2017.06.087.
Повний текст джерелаPark, Chun Shik, Andrew H. Lewis, Taylor J. Chen, Cory S. Bridges, Ye Shen, Koramit Suppipat, Monica Puppi, et al. "A KLF4-DYRK2–mediated pathway regulating self-renewal in CML stem cells." Blood 134, no. 22 (November 28, 2019): 1960–72. http://dx.doi.org/10.1182/blood.2018875922.
Повний текст джерелаWOODS, Yvonne L., Philip COHEN, Walter BECKER, Ross JAKES, Michel GOEDERT, Xuemin WANG та Christopher G. PROUD. "The kinase DYRK phosphorylates protein-synthesis initiation factor eIF2Bɛ at Ser539 and the microtubule-associated protein tau at Thr212: potential role for DYRK as a glycogen synthase kinase 3-priming kinase". Biochemical Journal 355, № 3 (24 квітня 2001): 609–15. http://dx.doi.org/10.1042/bj3550609.
Повний текст джерелаLi, Xu, Min Wang, Jian-Xin Jiang, Rui Tian, Cheng-Jian Shi, and Ren-Yi Qin. "Clinical significance of expression of DYRK2 in pancreatic cancer." World Chinese Journal of Digestology 21, no. 15 (2013): 1442. http://dx.doi.org/10.11569/wcjd.v21.i15.1442.
Повний текст джерелаNihira, Naoe Taira, and Kiyotsugu Yoshida. "Engagement of DYRK2 in proper control for cell division." Cell Cycle 14, no. 6 (March 19, 2015): 802–7. http://dx.doi.org/10.1080/15384101.2015.1007751.
Повний текст джерелаYoshida, Saishu, and Kiyotsugu Yoshida. "Multiple functions of DYRK2 in cancer and tissue development." FEBS Letters 593, no. 21 (September 18, 2019): 2953–65. http://dx.doi.org/10.1002/1873-3468.13601.
Повний текст джерелаLaham, Amina Jamal, Raafat El-Awady, Jean-Jacques Lebrun, and Maha Saber Ayad. "A Bioinformatics Evaluation of the Role of Dual-Specificity Tyrosine-Regulated Kinases in Colorectal Cancer." Cancers 14, no. 8 (April 18, 2022): 2034. http://dx.doi.org/10.3390/cancers14082034.
Повний текст джерелаKarpov, Pavel, Aleksey Raevsky, Maxim Korablyov, and Yaroslav Blume. "Identification of Plant Homologues of Dual Specificity Yak1-Related Kinases." Computational Biology Journal 2014 (December 8, 2014): 1–14. http://dx.doi.org/10.1155/2014/909268.
Повний текст джерелаHossain, Delowar, Jérémy A. Ferreira Barbosa, Éric A. Cohen, and William Y. Tsang. "HIV-1 Vpr hijacks EDD-DYRK2-DDB1DCAF1to disrupt centrosome homeostasis." Journal of Biological Chemistry 293, no. 24 (May 3, 2018): 9448–60. http://dx.doi.org/10.1074/jbc.ra117.001444.
Повний текст джерелаSun, Wei, Shuang Jiao, Xungang Tan, Peijun Zhang, and Feng You. "DYRK2 displays muscle fiber type specific function during zebrafish early somitogenesis." International Journal of Developmental Biology 61, no. 6-7 (2017): 459–63. http://dx.doi.org/10.1387/ijdb.160175sj.
Повний текст джерелаLuebbering, Nathan, Mark Charlton-Perkins, Justin P. Kumar, Stephanie M. Rollmann, Tiffany Cook, and Vaughn Cleghon. "Drosophila Dyrk2 Plays a Role in the Development of the Visual System." PLoS ONE 8, no. 10 (October 11, 2013): e76775. http://dx.doi.org/10.1371/journal.pone.0076775.
Повний текст джерелаBahl, Anu, Prashant Joshi, Sandip B. Bharate, and Harish Chopra. "Pharmacophore modeling and 3D-QSAR studies of leucettines as potent Dyrk2 inhibitors." Medicinal Chemistry Research 23, no. 4 (September 26, 2013): 1925–33. http://dx.doi.org/10.1007/s00044-013-0767-1.
Повний текст джерелаMimoto, Rei, Naoe Taira, Hiroyuki Takahashi, Tomoko Yamaguchi, Masataka Okabe, Ken Uchida, Yoshio Miki, and Kiyotsugu Yoshida. "DYRK2 controls the epithelial–mesenchymal transition in breast cancer by degrading Snail." Cancer Letters 339, no. 2 (October 2013): 214–25. http://dx.doi.org/10.1016/j.canlet.2013.06.005.
Повний текст джерелаJung, Hae-Yun, Xin Wang, Sohee Jun, and Jae-Il Park. "Dyrk2-associated EDD-DDB1-VprBP E3 Ligase Inhibits Telomerase by TERT Degradation." Journal of Biological Chemistry 288, no. 10 (January 28, 2013): 7252–62. http://dx.doi.org/10.1074/jbc.m112.416792.
Повний текст джерелаPérez, Moisés, Carmen García-Limones, Inés Zapico, Anabel Marina, M. Lienhard Schmitz, Eduardo Muñoz, and Marco A. Calzado. "Mutual regulation between SIAH2 and DYRK2 controls hypoxic and genotoxic signaling pathways." Journal of Molecular Cell Biology 4, no. 5 (August 9, 2012): 316–30. http://dx.doi.org/10.1093/jmcb/mjs047.
Повний текст джерелаXu, Li, Yuxiang Sun, Mengmeng Li, and Xin Ge. "Dyrk2 mediated the release of proinflammatory cytokines in LPS-induced BV2 cells." International Journal of Biological Macromolecules 109 (April 2018): 1115–24. http://dx.doi.org/10.1016/j.ijbiomac.2017.11.095.
Повний текст джерелаVerPlank, Jordan J. S., and Alfred L. Goldberg. "Regulating protein breakdown through proteasome phosphorylation." Biochemical Journal 474, no. 19 (September 25, 2017): 3355–71. http://dx.doi.org/10.1042/bcj20160809.
Повний текст джерелаMaddika, Subbareddy, and Junjie Chen. "Protein kinase DYRK2 is a scaffold that facilitates assembly of an E3 ligase." Nature Cell Biology 11, no. 4 (March 15, 2009): 409–19. http://dx.doi.org/10.1038/ncb1848.
Повний текст джерелаCuny, Gregory D., Maxime Robin, Natalia P. Ulyanova, Debasis Patnaik, Valerie Pique, Gilles Casano, Ji-Feng Liu, et al. "Structure–activity relationship study of acridine analogs as haspin and DYRK2 kinase inhibitors." Bioorganic & Medicinal Chemistry Letters 20, no. 12 (June 2010): 3491–94. http://dx.doi.org/10.1016/j.bmcl.2010.04.150.
Повний текст джерелаMimoto, R., Y. Imawari, S. Hirooka, H. Takeyama, and K. Yoshida. "Impairment of DYRK2 augments stem-like traits by promoting KLF4 expression in breast cancer." Oncogene 36, no. 13 (October 10, 2016): 1862–72. http://dx.doi.org/10.1038/onc.2016.349.
Повний текст джерелаAn, Tai, Shu Li, Wei Pan, Po Tien, Bo Zhong, Hong-Bing Shu, and Shuwen Wu. "DYRK2 Negatively Regulates Type I Interferon Induction by Promoting TBK1 Degradation via Ser527 Phosphorylation." PLOS Pathogens 11, no. 9 (September 25, 2015): e1005179. http://dx.doi.org/10.1371/journal.ppat.1005179.
Повний текст джерелаWeiss, Celine S., Marco M. Ochs, Marco Hagenmueller, Marcus R. Streit, Pratima Malekar, Johannes H. Riffel, Sebastian J. Buss та ін. "DYRK2 Negatively Regulates Cardiomyocyte Growth by Mediating Repressor Function of GSK-3β on eIF2Bε". PLoS ONE 8, № 9 (4 вересня 2013): e70848. http://dx.doi.org/10.1371/journal.pone.0070848.
Повний текст джерелаEnomoto, Yasuko, Shin-ichi Yamashita, Yasuteru Yoshinaga, Yasuyoshi Fukami, So Miyahara, Kazuki Nabeshima, and Akinori Iwasaki. "Downregulation of DYRK2 can be a predictor of recurrence in early stage breast cancer." Tumor Biology 35, no. 11 (August 6, 2014): 11021–25. http://dx.doi.org/10.1007/s13277-014-2413-z.
Повний текст джерелаZhang, Xiubing, Pan Xu, Wenkai Ni, Hui Fan, Jian Xu, Yongmei Chen, Wei Huang, et al. "Downregulated DYRK2 expression is associated with poor prognosis and Oxaliplatin resistance in hepatocellular carcinoma." Pathology - Research and Practice 212, no. 3 (March 2016): 162–70. http://dx.doi.org/10.1016/j.prp.2016.01.002.
Повний текст джерелаYamaguchi, Noriko, Rei Mimoto, Nozomu Yanaihara, Yoshimi Imawari, Shinichi Hirooka, Aikou Okamoto, and Kiyotsugu Yoshida. "DYRK2 regulates epithelial-mesenchymal-transition and chemosensitivity through Snail degradation in ovarian serous adenocarcinoma." Tumor Biology 36, no. 8 (February 25, 2015): 5913–23. http://dx.doi.org/10.1007/s13277-015-3264-y.
Повний текст джерелаWang, Yuchan, Yaxun Wu, Xiaobing Miao, Xinghua Zhu, Xianjing Miao, Yunhua He, Fei Zhong, et al. "Silencing of DYRK2 increases cell proliferation but reverses CAM-DR in Non-Hodgkin's Lymphoma." International Journal of Biological Macromolecules 81 (November 2015): 809–17. http://dx.doi.org/10.1016/j.ijbiomac.2015.08.067.
Повний текст джерелаSun, Wei, Xungang Tan, Peijun Zhang, Yuqing Zhang, and Yongli Xu. "Characterization of DYRK2 (dual-specificity tyrosine-phosphorylation-regulated kinase 2) from Zebrafish (Dario rerio)." Chinese Journal of Oceanology and Limnology 28, no. 4 (June 29, 2010): 720–24. http://dx.doi.org/10.1007/s00343-010-9073-7.
Повний текст джерелаYokoyama-Mashima, Shiho, Satomi Yogosawa, Yumi Kanegae, Shinichi Hirooka, Saishu Yoshida, Takashi Horiuchi, Toya Ohashi, et al. "Forced expression of DYRK2 exerts anti-tumor effects via apoptotic induction in liver cancer." Cancer Letters 451 (June 2019): 100–109. http://dx.doi.org/10.1016/j.canlet.2019.02.046.
Повний текст джерелаAuld, Gillian C., David G. Campbell, Nick Morrice, and Philip Cohen. "Identification of calcium-regulated heat-stable protein of 24 kDa (CRHSP24) as a physiological substrate for PKB and RSK using KESTREL." Biochemical Journal 389, no. 3 (July 26, 2005): 775–83. http://dx.doi.org/10.1042/bj20050733.
Повний текст джерелаBoni, Jacopo, Carlota Rubio-Perez, Nuria López-Bigas, Cristina Fillat, and Susana de la Luna. "The DYRK Family of Kinases in Cancer: Molecular Functions and Therapeutic Opportunities." Cancers 12, no. 8 (July 29, 2020): 2106. http://dx.doi.org/10.3390/cancers12082106.
Повний текст джерелаTaira, Naoe, Hiroyuki Yamamoto, Tomoko Yamaguchi, Yoshio Miki, and Kiyotsugu Yoshida. "ATM Augments Nuclear Stabilization of DYRK2 by Inhibiting MDM2 in the Apoptotic Response to DNA Damage." Journal of Biological Chemistry 285, no. 7 (December 4, 2009): 4909–19. http://dx.doi.org/10.1074/jbc.m109.042341.
Повний текст джерелаMimoto, Rei, Naoe T. Nihira, Shinichi Hirooka, Hiroshi Takeyama, and Kiyotsugu Yoshida. "Diminished DYRK2 sensitizes hormone receptor-positive breast cancer to everolimus by the escape from degrading mTOR." Cancer Letters 384 (January 2017): 27–38. http://dx.doi.org/10.1016/j.canlet.2016.10.015.
Повний текст джерелаTANAKA, MASUMI, SHIN-ICHI YAMASHITA, YASUTERU YOSHINAGA, YASUKO ENOMOTO, YUKI NOHARA, SYUKO ONO, KAZUKI NABESHIMA, AKINORI IWASAKI, and TOSHIHIKO SATO. "Combination of DYRK2 and TERT Expression Is a Powerful Predictive Marker for Early-stage Breast Cancer Recurrence." Anticancer Research 42, no. 4 (March 28, 2022): 2079–85. http://dx.doi.org/10.21873/anticanres.15689.
Повний текст джерелаZhang, Xiaojing, Runze Xiao, Bing Lu, Han Wu, Chunyi Jiang, Peng Li, and Jianfei Huang. "Kinase DYRK2 acts as a regulator of autophagy and an indicator of favorable prognosis in gastric carcinoma." Colloids and Surfaces B: Biointerfaces 209 (January 2022): 112182. http://dx.doi.org/10.1016/j.colsurfb.2021.112182.
Повний текст джерелаTaira, Naoe, Rei Mimoto, Morito Kurata, Tomoko Yamaguchi, Masanobu Kitagawa, Yoshio Miki, and Kiyotsugu Yoshida. "DYRK2 priming phosphorylation of c-Jun and c-Myc modulates cell cycle progression in human cancer cells." Journal of Clinical Investigation 122, no. 3 (March 1, 2012): 859–72. http://dx.doi.org/10.1172/jci60818.
Повний текст джерелаRyu, Ki-Jun, Sun-Mi Park, Seung-Ho Park, In-Kyu Kim, Hyeontak Han, Hyo-Jin Kim, Seon-Hee Kim та ін. "p38 Stabilizes Snail by Suppressing DYRK2-Mediated Phosphorylation That Is Required for GSK3β-βTrCP–Induced Snail Degradation". Cancer Research 79, № 16 (17 червня 2019): 4135–48. http://dx.doi.org/10.1158/0008-5472.can-19-0049.
Повний текст джерелаNishi, Y., E. Rogers, S. M. Robertson, and R. Lin. "Polo kinases regulate C. elegans embryonic polarity via binding to DYRK2-primed MEX-5 and MEX-6." Development 135, no. 4 (February 15, 2008): 687–97. http://dx.doi.org/10.1242/dev.013425.
Повний текст джерела